# Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)

> **NCT00096460** · PHASE2,PHASE3 · TERMINATED · sponsor: **Medical College of Wisconsin** · enrollment: 30 (actual)

## Conditions studied

- Recurrent Grade 1 Follicular Lymphoma
- Recurrent Grade 2 Follicular Lymphoma
- Recurrent Grade 3 Follicular Lymphoma
- Follicular Lymphoma

## Interventions

- **DRUG:** Cyclophosphamide and Rituximab
- **DRUG:** Filgrastim
- **RADIATION:** Chemotherapy or Radiation therapy
- **DRUG:** Non-myeloablative Conditioning regimen
- **PROCEDURE:** Allogeneic transplant
- **PROCEDURE:** Autologous transplant
- **DRUG:** Rituximab maintenance therapy
- **DRUG:** GVHD Prophylaxis

## Key facts

- **NCT ID:** NCT00096460
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-08
- **Primary completion:** 2006-03
- **Final completion:** 2009-03
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** lower than anticipated accrual
- **Last updated:** 2023-01-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00096460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00096460, "Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00096460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*